The 1873 Law That Could Shut Down Mail-Order Abortion Pills Overnight

After saying abortion should go “back to the states,” federal courts and regulators are now helping keep a national abortion pill pipeline wide open.

Story Snapshot

Federal lawsuits over the abortion pill mifepristone now decide what every state can and cannot do.
The Supreme Court has repeatedly stepped in to keep mail and telehealth access to the pill in place nationwide.
Pro‑life doctors and states are being told they lack “standing,” while the Food and Drug Administration (FDA) faces almost no check.
A forgotten 1800s anti‑obscenity law, the Comstock Act, looms as a possible nationwide brake on abortion by mail.

How a “State Issue” Turned Into a National Abortion Pill Fight

After the Supreme Court reversed Roe v. Wade and returned abortion policy to the states, many Americans thought each state would now set its own limits. That has not happened with abortion pills. Instead, abortion activists and drug makers have shifted the battle to federal courtrooms and to the Food and Drug Administration. A lawsuit by pro‑life doctors, Alliance for Hippocratic Medicine v. Food and Drug Administration, directly challenged the agency’s approval and later loosening of rules for mifepristone, the most common abortion pill.^[1]

That case asked federal judges to roll back changes that let women get mifepristone by mail and through telehealth, even in states that passed strong pro‑life laws.^[1] At the same time, other cases were filed by abortion‑friendly groups and by the pill’s own manufacturer to protect broad access.^[3] These lawsuits aim straight at the heart of state authority. If a federal judge says abortion pills must be available nationwide under federal drug rules, then many state laws are weakened before they can be fully enforced.^[3]

Supreme Court Rulings Keep Mail‑Order Abortion Alive

Federal appeals courts briefly tried to tighten access by restoring older rules that required women to see a doctor in person before getting mifepristone.^[3] Abortion supporters called that a “major win,” saying it would sharply cut online and mail prescription abortions. In response, the pill’s manufacturer rushed to the Supreme Court and warned of confusion and fewer abortions if mail access ended.^[3] This pressure helped turn the fight into a national emergency in the eyes of the media and the courts.

The Supreme Court has now stepped in more than once to keep the pill widely available while lawsuits continue.^[2]^[5] In one order, the Court restored broad access, allowing mifepristone to be dispensed at pharmacies or sent by mail instead of requiring in‑person visits.^[2] More recently, the Court unanimously threw out the pro‑life doctors’ challenge, saying they did not have legal standing to sue over the Food and Drug Administration’s actions.^[4] That ruling left in place the agency’s 2016 and 2021 expansions of access, including telehealth and longer use in pregnancy.^[4]

Standing, the Food and Drug Administration, and the Power of Unelected Officials

By focusing on “standing,” the Court avoided ruling on whether the Food and Drug Administration followed the law when it approved mifepristone and later relaxed safeguards.^[4] Pro‑life doctors argued that the agency cut safety corners and exposed women to greater risks to speed up access. Instead of weighing those claims, the Court said these doctors and medical groups could not show a direct enough injury. The case was tossed on a technical rule, and the agency’s decisions stayed in place.^[4]

This approach fits a wider pattern where federal judges say policy fights belong at the ballot box, yet their rulings still decide what happens nationwide right now.^[3] While states try to enforce abortion bans, the Food and Drug Administration’s national label for mifepristone, along with telehealth, makes it easier for out‑of‑state providers to reach women everywhere.^[3] Some Democratic‑led states even passed laws to shield doctors who prescribe abortion pills by telehealth into pro‑life states.^[2] The result is a tug‑of‑war: elected state lawmakers on one side, and unelected regulators and distant judges on the other.

The Comstock Act and the Question No One Wants to Answer

Hidden under all of this is the Comstock Act, an 1873 federal law that bans mailing items used to perform abortions. For years, people called it a “zombie law,” still on the books but largely ignored.^[1] When a recent Louisiana case over telehealth and mail‑order mifepristone reached the Supreme Court, Justices Samuel Alito and Clarence Thomas dissented, arguing that shipping abortion pills by mail likely violates that law.^[1] Their view would shut down the national abortion pill pipeline overnight.

The Department of Justice under President Joe Biden issued a memo in 2022 claiming that the Comstock Act does not block mailing abortion drugs unless the sender knows they will be used illegally.^[1] Abortion advocates have leaned on that reading to push mail‑order pills into even the most pro‑life states. Pro‑life groups, on the other hand, see Comstock as a powerful tool to defend life nationwide and to support states that chose to protect unborn children after Roe fell. For now, the Supreme Court has sidestepped that clash, but the issue is almost certain to return.^[1]

What This Means for Pro‑Life States and Conservative Voters

For families who value life and believe in local control, this fight shows how fragile “states’ rights” can be when federal agencies and courts lean the other way. Even as many states pass strong pro‑life laws, abortion pills still make up most abortions in America, and a large share are now prescribed through telehealth.^[3] That reality blunts the impact of state bans and creates deep confusion for women, doctors, and pharmacists caught between state laws and federal rules.^[3]

Looking ahead, these court battles are about more than one drug. They test how much power the Food and Drug Administration has over sensitive moral issues and how far federal judges can go in overriding state choices on life, medicine, and family. Pro‑life Americans who thought the debate ended with Roe now face a new front: a legal war over pills, mail, and telehealth that will decide whether states can truly choose a culture of life, or whether federal power will keep pushing abortion everywhere, whether voters like it or not.^[3]